Efficient study design for next generation sequencing
โ Scribed by Joshua Sampson; Kevin Jacobs; Meredith Yeager; Stephen Chanock; Nilanjan Chatterjee
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 170 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0741-0395
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Next Generation Sequencing represents a powerful tool for detecting genetic variation associated with human disease. Because of the high cost of this technology, it is critical that we develop efficient study designs that consider the tradeโoff between the number of subjects (n) and the coverage depth (ยต). How we divide our resources between the two can greatly impact study success, particularly in pilot studies. We propose a strategy for selecting the optimal combination of n and ยต for studies aimed at detecting rare variants and for studies aimed at detecting associations between rare or uncommon variants and disease. For detecting rare variants, we find the optimal coverage depth to be between 2 and 8 reads when using the likelihood ratio test. For association studies, we find the strategy of sequencing all available subjects to be preferable. In deriving these combinations, we provide a detailed analysis describing the distribution of depth across a genome and the depth needed to identify a minor allele in an individual. The optimal coverage depth depends on the aims of the study, and the chosen depth can have a large impact on study success. Genet. Epidemiol. 35: 269โ277, 2011.โโยฉ 2011 WileyโLiss, Inc.
๐ SIMILAR VOLUMES
## Abstract Most common hereditary diseases in humans are complex and multifactorial. Largeโscale genomeโwide association studies based on SNP genotyping have only identified a small fraction of the heritable variation of these diseases. One explanation may be that many rare variants (a minor allel
Recent advances in next-generation sequencing technologies make it affordable to search for rare and functional variants for common complex diseases systematically. We investigated strategies for enriching rare variants in the samples selected for sequencing so as to optimize the power for their dis
## Abstract For Abstract see ChemInform Abstract in Full Text.